Abstract
Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer´s disease risk
increased cellular cholesterol levels inducing high amyloid beta (Aβ) production and the development of neurofibrillary tangles [1, 2] , which are central to the pathogenesis of AD.
Niemann-Pick C1 (NPC1) protein and ATP-binding cassette transporter A1 (ABCA1) protein affect redistributing late endosomal/lysosomal intracellular cholesterol transport to other cellular sites including the plasma membrane and the endoplasmic reticulum [3, 4] . The most striking biochemical feature of NPC1-or ABCA1-deficient cells is an excessive storage of unesterified cholesterol in late endosomes/lysosomes [1, 2] . In recent genome-wide association studies [5, 6] , genetic markers of the ABCA1 region showed a weak association to AD [5] , but markers of the NPC1 region were not found associated to AD [5, 6] . In addition, variability in NPC1
[7] and ABCA1 [8-12] genes has been proposed to modify the risk of AD through an independent effect.
However, the interactive effect between polymorphisms of two genes (epistasis) may exist without a significant main effect of either of them, and in such cases, the effect would have been missed if polymorphisms of both genes had not been tested jointly [13] . Therefore, and considering the postulated common pathway of NPC1 and ABCA1 in intracellular cholesterol trafficking, we examined the combined contribution of these genes to the susceptibility for AD in a case-control study. Our hypothesis is that there may be functional variants in the NPC1 and ABCA1 genes that would predispose people to AD due to underexpression of the NPC1 gene in concert with underexpression of the ABCA1 gene. We focused on a functional polymorphism in the ABCA1 (−477, rs2422493) gene [14] previously associated with AD risk [11, 15] , and we also examined one NPC1 polymorphism in exon 6 (rs18050810) previously analyzed in AD [7] and three other NPC1 polymorphisms in intron 20 (rs4800488), intron 22 (rs2236707), and intron 24 (rs2510344).
Methods
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Subjects. The study included 631 AD patients (65% women; mean age at study 75.9 years; SD 8.1; range 61-109 years; mean age at onset 72.8 years; SD 7.8; range 60-100 years) who met NINCDS/ADRDA criteria for probable AD [16] . All AD cases were defined as sporadic because their family history did not mention any first-degree relative with dementia. AD patients were recruited from the Departments of Neurology of University Hospital "Marqués de Valdecilla" (Santander, Spain), and Hospital "La Paz" (Madrid, Spain). The large majority of patients were living in the community and had been referred by their general practitioner; few had been admitted from hospital wards or nursing home facilities. Control subjects were 731 unrelated individuals (65% women; mean age 78.6 years; SD 9.4; range 60-104 years) randomly selected from nursing homes. These subjects had complete neurologic and medical examinations that showed that they were free of significant illness and had Mini Mental State Examination scores of 28 or more, which were verified by at least one subsequent annual following-up assessment.
The controls arose from the same base population as the cases. The AD and control samples
were Caucasians originating from a limited geographical area in northern Spain (Santander) and from the central area of Spain (Madrid).
Genotyping. Blood samples were taken after written informed consent had been obtained from the subjects or their representatives. The study was approved by the ethical committees of the University Hospital "Marqués de Valdecilla" and the Hospital "La Paz". Genotyping of NPC1 (rs18050810, rs4800488, rs2236707, and rs2510344) polymorphism was performed by a TaqMan single-nucleotide-polymorphism assay (Applied Biosystems, Warrington, Cheshire, UK)
and an ABI PRISM 7000 or 7900HT sequence detection systems (Applied Biosystems). We used data from the HapMap project (http://www.hapmap.org) to select the 4 htSNPs capturing 85% of NPC1 genetic variability in Caucasians. SNPs were chosen among those with minor allele frequencies ≥5% using Haploview v3.2 software (http://www.broad.mit.edu/mpg/haploview) with an r 2 threshold of 0.8. The ABCA1 (−477, rs2422493) polymorphism was determined as described previously [9] . APOE genotyping was performed by amplification of the 4th exon of the APOE gene by PCR with biotinylated primers, followed by reverse hybridization on nitrocellulose strips, using the INNO-LIPA ApoE assay polymorphisms did not differ significantly between AD and control groups ( (Table 2 ). Since the four NPC1 polymorphisms in our study are in almost complete linkage disequilibrium forming one block, we have tested only three independent comparisons examining the interaction between the ABCA1 and NPC1 genes; therefore, when applying the conservative Bonferroni adjustment, statistical significance should be set up at p < 0.017, which is reached by the interaction between ABCA1 (−477) and NPC1 homozygosity for the HMGCR 5´-UTR (the major rate-limiting enzyme in the novo synthesis of cholesterol,) G allele has been associated with increased AD risk [15] . The ABCA1 (−477) polymorphism located in the promoter region has a functional effect: luciferase reporter assay indicates that the ABCA1 (−477) C allele has significantly higher promoter activity than the 7 ABCA1 (−477) T allele promoter [14] . So, we hypothesized that subjects carrying the low show the same pattern of tau hyperphosphorylation [20] . In addition, tangle-bearing neurons in AD contain more unesterified cholesterol than do tangle-free neurons [21] suggesting that a sequestration of cholesterol, such as occurs in NPC disease, might influence tangle formation. It has been suggested that cholesterol may also modulate Aβ formation, a causative factor of AD [1] ; so, the intracellular accumulation of cholesterol in the brain of a mouse model of NPC disease enhances amyloidogenesis via enhancement of γ-secretase activity, which correlates with an increase in Aβ levels [22] . Recent findings have suggested an interaction of ABCA1 and NPC1 proteins in intracellular cholesterol trafficking: in cultured NPC1-deficient fibroblasts ABCA1 expression was decreased and the ABCA1-dependent efflux of cholesterol was impaired [23] .
Results
Control
Although important result has been derived from the study of their epistatic (gene-gene) interaction [13] . In fact, with the current one-SNP-at-a-time approach to genomewide association studies, failure to replicate a genetic association in a second sample can be an indication that single SNPs contribute to disease susceptibility through interactions with one or more other SNPs [24] .
Moreover, it has been proposed that patterns of SNPs in biochemical pathways, such as the cholesterol trafficking pathway analyzed in the present study, are more likely to replicate than individual and non-related SNPs [25] . Additional studies using different sets of patients and control subjects are required to verify the validity of our hypotheses (genetic and biologic). 
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